1 / 20

Dupuytren ’ s Contracture: Not Just A Disease for Vikings

Dupuytren ’ s Contracture: Not Just A Disease for Vikings. Presented by Michael Mangonon, DO, FACOS Atlanta Hand Specialist. Conflict of Interest Disclosure I have no conflicts and nothing to disclose. Abnormal thickening of fascia located in the palm

sguillermo
Download Presentation

Dupuytren ’ s Contracture: Not Just A Disease for Vikings

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Dupuytren’s Contracture:Not Just A Disease for Vikings Presented by Michael Mangonon, DO, FACOS Atlanta Hand Specialist

  2. Conflict of Interest Disclosure I have no conflicts and nothing to disclose

  3. Abnormal thickening of fascia located in the palm • Tightening of the fascia can lead to Dupuytren’s Contracture • Affects 10 million Americans (30 million worldwide) • No prevention or cure • Celebrities with the disease include Ronald Reagan, Margaret Thatcher, Mitt Romney, Paul Newman, Frank Sinatra, Bill Murray, John Elway What is Dupuytren’s Disease?

  4. History • Traditionally thought that disease originated in the Vikings who spread it throughout Northern Europe during their conquests • Earliest description by Felix Platter in 1680 • Named after Baron Guillaume Dupuytren who gave the defining lecture describing the disease on December 5, 1831 What is Dupuytren’s Disease?

  5. Patients present with difficulty performing daily activities • placing hands in pockets, putting on gloves, shaking hands, grasping large objects, reaching into narrow spaces, cleaning hands • Usually slow progression • Without contracture there may be no treatment needed • 1 in 10 patients do not progress to contracture Progression of the Disease

  6. Exact cause is unknown • Disease linked to smoking, alcohol, diabetes, nutritional deficiencies, seizure disorder medications • No evidence has linked the disease to occupation, injury, or surgery (although patients describe it anecdotally) Causes

  7. Age > 40 • Men > Women • Diabetes • Family history • Can skip generations • Northern European decent • English, Irish, Scottish, French, Dutch • Scandinavian descent • Swedish, Norwegian, Finnish • When disease occurs at a younger age it tends to progress more severely Risk Factors

  8. Arthritis • Tendonitis / Trigger Finger • Joint dislocation • Extensor tendon rupture Differential Diagnosis

  9. Fascia • fibrous layer of tissue below the skin but superficial to the tendon in the palm and fingers • Anchors and stabilizes the palmar skin • Needed for gripping, as compared to mobile skin on the dorsum of the hand Anatomy

  10. Nodules, puckering, dimpling, pitting, and cord formation in the palm • Can occur from the level of the proximal palm to the distal interphalangeal joint • Mainly affects the small and ring fingers but can affect any finger (rarely the thumb and index finger are affected) • Nodules can be sensitive to touch but usually not painful • Contractures • occur when cords thicken and shorten • Fingers are pulled into a flexed position • More commonly occurs in metacarpophalangeal joints but also seen in proximal and distal interphalangeal joints • Also present in the feet as Ledderhose Disease and in the penis as Peyronie’s Disease Signs / Symptoms

  11. Visual exam • Nodules, pitting, cords • Garrod’s nodes (knuckle pads, on the dorsum of the PIP joints) • ROM testing – to determine degree of contractures and which joints are affected • Sensation testing • Table Top Test – positive when hand and fingers cannot be placed flat onto a table Physical Exam

  12. X-ray • Arthritis • Joint dislocation • MRI • Soft tissue mass • Tendon pathology Testing

  13. No cure for the disease • Goal of treatment is to improve contractures and increase ROM • Non-surgical • Splinting • Does not prevent progression • Steroid injection • Into painful nodules • May slow progression • Radiation • Used for prevention when nodules present without contracture • Though recent studies show rates of progression equal to or greater than no treatment Treatment Options

  14. Procedures • Needle Aponeurotomy • Insert needle into cord percutaneously and use the sharp bevel to cut the cord • Achieves extension right away • Risk of injury to tendon, vessel, nerve • High recurrence rate • Enzyme Injection • Inject enzyme into cord to cause weakening of the tissue then manipulate 24-72 hours later to break and separate the cord to allow extension • Risk of allergic reaction and tendon rupture • High recurrence rate • 2nd most common treatment currently Treatment Options

  15. Surgical • Fasciotomy • Incision made over cord, cord dissected and cut using knife, wound left open to heal by secondary intention • Fasciectomy • Large incision made along the length of the cord, cord dissected to protect surrounding structures, excision of as much cord and affected tissue is needed to obtain extension, wound closed • Most common treatment currently • Dermofasciectomy • Similar to fasciectomy but includes removal of affected overlying skin, requires skin graft for closure Treatment Options

  16. Recurrence • Pain • Scarring • Injury to vessels, nerves, or tendons • Wound infection • Stiffness • Loss of sensation • Loss of viability • Allergic reaction (enzyme injection) • Tendon rupture (enzyme injection) Risks and Complications of Surgery

  17. Hand therapy • Starts within days post-op • Proper splint to protect wound and maintain extension while healing • Increase extension • Maintain flexion/gip • Increase strength • Improve function • Scar management • Improve long-term outcome Post-operative Management

  18. Complete extension may not always be possible • Improvement is often partial and temporary • Goal is to regain functional ROM as opposed to full ROM • Repeat procedures are likely less effective with increased risk • 2 in 100 with nodules progress to contracture yearly • Recurrence • Needling – 85% • Enzyme injection – 50-60% (only 5-year follow-up thus far) • Surgery – 20% Outcomes

  19. Questions?

  20. The End Thank you for your time and enjoy the rest of the conference!

More Related